QUOTE AND NEWS
The Hindu Business Line  Aug 27  Comment 
Panacea Biotec on Monday inked a tripartite pact with Natco Pharma and Breckenridge Pharmaceutical Inc to manufacture and supply Azacitidine injection
The Hindu Business Line  Aug 13  Comment 
Hyderabad-based NATCO Pharma Ltd has announced that its co-development and marketing partner, Dr Reddy’s Laboratories Ltd, has filed for doxorubicin
The Hindu Business Line  Jul 2  Comment 
Natco Pharma has launched a fixed dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcinat
The Hindu Business Line  May 23  Comment 
Natco Pharma has posted a profit of ₹299.7 core for the fourth quarter ended March 31, 2018, against a profit of ₹176.4 crore, up 69.9 per cent for th
The Economic Times  Apr 10  Comment 
Buy Natco Pharma Ltd. at a price target of Rs 908.
The Hindu Business Line  Apr 4  Comment 
 Natco Pharma on Wednesday launched a generic version of Teriflunomide for the treatment of relapsing and remitting forms of multiple sclerosis (RRMS)
The Hindu Business Line  Mar 15  Comment 
Investors with a short-term perspective can consider buying the stock of Natco Pharma at current levels. The stock encountered a key medium-term term resistance at around ₹1,050 in mid-January 2018
The Hindu Business Line  Mar 1  Comment 
Natco Pharma Ltd has filed an abbreviated new drug application (ANDA) for Sofosbuvir tablets with the United States Food and Drug Administration (USFDA), according to a company release issued here





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki